Preliminary efficacy, safety, and immunomodulatory effects of PT-112 from a phase 2 proof of concept study in patients (pts) with thymic epithelial tumors (TETs).
| Title: | Preliminary efficacy, safety, and immunomodulatory effects of PT-112 from a phase 2 proof of concept study in patients (pts) with thymic epithelial tumors (TETs). |
|---|---|
| Authors: | McAdams, Meredith, Swift, Shannon, Donahue, Renee N., Celades, Carolina, Tsai, Yo-Ting, Bingham, Molly, Szabo, Eva, Zhao, Chen, Sansone, Susan, Choradia, Nirmal, Shelat, Meenakshi, O'Donnell, Joseph Francis, Ames, Tyler David, Raphael, Brooke, Steinberg, Seth M., Gulley, James L., Schlom, Jeffrey, Rajan, Arun |
| Source: | Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pe20647-e20647, 1p |
| Database: | Supplemental Index |
Be the first to leave a comment!